59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Autor:	Christoph Springfeld, Rachna T. Shroff, A. de Gramont, Helena Verdaguer, Lipika Goyal, Daniel H. Palmer, Chiara Braconi, Paul Ross, J.O. Park, John Zalcberg, D-Y. Oh, Mairéad G McNamara, Jennifer J. Knox, Katrin Marie Sjoquist, Juan W. Valle, David O. Cosgrove
Rok vydání:	2021
Předmět:	Cisplatin First line treatment Biliary tract cancer Oncology business.industry Cancer research Medicine Gemcitabine/cisplatin Hematology business medicine.drug
Zdroj:	Annals of Oncology. 32:S381
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d9621e527dea1bc247f972d96d108d86 https://doi.org/10.1016/j.annonc.2021.08.338 Zobrazit plný text záznamu